Cargando…
The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454872/ https://www.ncbi.nlm.nih.gov/pubmed/36078047 http://dx.doi.org/10.3390/cells11172639 |
_version_ | 1784785454858502144 |
---|---|
author | Geers, Bernd Hagenstein, Julia Endig, Jessica Ulrich, Hanna Fleig, Laura Sprezyna, Paulina Mikulec, Julita Heukamp, Lukas Tiegs, Gisa Diehl, Linda |
author_facet | Geers, Bernd Hagenstein, Julia Endig, Jessica Ulrich, Hanna Fleig, Laura Sprezyna, Paulina Mikulec, Julita Heukamp, Lukas Tiegs, Gisa Diehl, Linda |
author_sort | Geers, Bernd |
collection | PubMed |
description | Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3(+) iT(reg) in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d(−/−) CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iT(reg) conversion via the restriction of IL-2 production, leading to reduced induction of T(reg) from conventional CD4 T cells. |
format | Online Article Text |
id | pubmed-9454872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94548722022-09-09 The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability Geers, Bernd Hagenstein, Julia Endig, Jessica Ulrich, Hanna Fleig, Laura Sprezyna, Paulina Mikulec, Julita Heukamp, Lukas Tiegs, Gisa Diehl, Linda Cells Article Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3(+) iT(reg) in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d(−/−) CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iT(reg) conversion via the restriction of IL-2 production, leading to reduced induction of T(reg) from conventional CD4 T cells. MDPI 2022-08-25 /pmc/articles/PMC9454872/ /pubmed/36078047 http://dx.doi.org/10.3390/cells11172639 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Geers, Bernd Hagenstein, Julia Endig, Jessica Ulrich, Hanna Fleig, Laura Sprezyna, Paulina Mikulec, Julita Heukamp, Lukas Tiegs, Gisa Diehl, Linda The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title | The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title_full | The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title_fullStr | The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title_full_unstemmed | The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title_short | The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability |
title_sort | adp-ribosylation factor 4d restricts regulatory t-cell induction via control of il-2 availability |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454872/ https://www.ncbi.nlm.nih.gov/pubmed/36078047 http://dx.doi.org/10.3390/cells11172639 |
work_keys_str_mv | AT geersbernd theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT hagensteinjulia theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT endigjessica theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT ulrichhanna theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT fleiglaura theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT sprezynapaulina theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT mikulecjulita theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT heukamplukas theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT tiegsgisa theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT diehllinda theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT geersbernd adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT hagensteinjulia adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT endigjessica adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT ulrichhanna adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT fleiglaura adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT sprezynapaulina adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT mikulecjulita adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT heukamplukas adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT tiegsgisa adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability AT diehllinda adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability |